ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BII Biocompatibles

429.00
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biocompatibles LSE:BII London Ordinary Share GB00B0L2JD04 ORD 21 53/94P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 429.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Biocompatibles Share Discussion Threads

Showing 1051 to 1070 of 1600 messages
Chat Pages: Latest  52  51  50  49  48  47  46  45  44  43  42  41  Older
DateSubjectAuthorDiscuss
03/12/2003
00:16
The Needham saga makes a sorry tale. Why do shareholders put up with him?


Law Society get involved:-

2bob
02/12/2003
21:12
-->scribbler
That's an easy one. Chance will be twice infinity of course! LOL

If the stock bubbles in the morning this could be the reason:-

Medtronic Applies to FDA for Drug-Eluting Stent Trial


Cheers
2Bob

2bob
27/11/2003
18:42
2BOB - Your chances will increase inifinitely if you buy a ticket.

So how much will they increase if you buy two?

scribbler101
21/11/2003
11:31
Ultrasis (ULT) a potential 10 to 20 bagger short-term imo.
qazwsx123
19/11/2003
21:01
Sir Richard Needham (somehow still BII Chairman) et al face fresh fraudulent trading claims:-


The book will make interesting reading:-


Cheers
2Bob

2bob
16/11/2003
21:03
-->piccolino
Angiotech chose to buy STS Polymers and not Biocompatibles or Lombard Medical.


Angiotech announces agreement to acquire STS Biopolymers, Inc.

2bob
16/11/2003
13:19
drago/2BOB

spoke to my broker... they kindly gave me less shares, but no mention of the dividend - seems a bit fishy to me..!!

davidcod
14/11/2003
12:53
-->davidcod
Have you asked your broker or the registrars or the company secretary?

-->drago
From recent RNS
"£17.6 million continues to be held in escrow pending conclusion of the
litigation between the remaining parties. Upon the conclusion of that litigation
and the release of the escrow account, Biocompatibles will then apply to the
High Court for a further repayment to its shareholders of £11.1 million, the
equivalent of up to approximately 29p per new ordinary share post consolidation.
The precise amount will depend upon the actual number of new ordinary post
consolidation shares issued at the time of the High Court application."

2bob
14/11/2003
12:35
david,
i havn't checked. last time my broker wrote a wee letter to say what cash had come in and what the consolidation was and what the new nos of shares were.

i thought there were more court cases to go through before the cash in escrow was released.

drago
13/11/2003
17:30
re my post 63... has anybody??
davidcod
13/11/2003
15:54
-->drago
Having seen the drug elution profile for ABT 578 (it comes off very fast)in a Medtronic presentation one wonders if the drug being used in the HCC trial will hang around long enough to do the job. A contolled slower elution might be in order along the lines of what Lombard Medical say they can do:-



PEP™ Microspheres

Lombard Medical has developed microspheres for embolisation therapy and believes it is possible to adapt PEP™ technology into programmable drug eluting microspheres for chemo-embolisation of malignant tumours.

The technology will allow multiple drugs to be eluted at different rates by combining, for example, PEP™ 95 microspheres with drug A and PEP™ 90 microspheres with drug B. The PEP™ numbering system reflects the hydrophobic : hydrophilic ratio of the
co-polymer which controls the elution profile of a given drug.

2bob
13/11/2003
15:28
does anyone know if there will be another share consolidation when the second half of the payout is given?
roogog
12/11/2003
11:26
any other biotech and there would be detailed discussions on their liver cancer prospects, stent revenues, and fibroid treatment.
but no.
are we all here for the cash returns?

drago
11/11/2003
20:26
2Bob – I have only just troubled to follow your links in post 59.
W o r r y i n g.

I have held onto some BII since Lodger said sell! Now the press, inc Sh*res Mag seem to have a positive view of prospects, and I have seen no critical reference to Sir Richard other than yours.

With shares held in a nominee account, I don't feel as well informed as I could be – and I rarely exercise voting rights.
But I do thank you, and others, for real contributions to this BB.

Incidentally, why all the sells today - have others just noticed/considered the presence of Needham at BII?

graphit
11/11/2003
14:50
has anybody not received there 25p dividend yet..?? or am i the only one !!
davidcod
09/11/2003
19:37
Are shareholders happy to have Needham leading them?
2bob
02/11/2003
19:03
At 1 in 2000 patients, it hardly seems a great incidence.
scribbler101
29/10/2003
16:50
Johnson & Johnson have a big problem with their drug-coated stents:
solomon
23/10/2003
21:25
No one getting excited about the deal with Terumowho sorry I mean Turumo?

No sign of Angiotech yet picco. Have they been sent homeward empty handed, again?

Cheers
2Bob

2bob
15/10/2003
00:41
-->Rayrac
That must be the one I posted a link to in post 44 on 23rd September :-)

-->piccolino
Good to hear from you. I did wonder to myself when typing post 48 what ANPI would do with all that money. It has long been suspected that, considering the stable Jeremy Curnock Cook came from and the dark forces around him, they would engineer something from that quarter.

What would it take to get Crispy to throw in the towel?

Cheers
2Bob

2bob
Chat Pages: Latest  52  51  50  49  48  47  46  45  44  43  42  41  Older

Your Recent History

Delayed Upgrade Clock